Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Setipiprant in seasonal allergic rhinitis
NCT01484119Phase 3Completed
- Sponsor
- Idorsia
- Start
- Dec 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of setipiprant in seasonal allergic rhinitis (SAR), sponsored by Idorsia. Started Dec 2011; status: completed.
02
Drugs
setipiprant
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01484119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01484119.